H. Roché
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 8
- HER2/EGFR in Cancer Research 4
- PARP inhibition in cancer therapy 2
-
- Breast Cancer Treatment Studies 5
- Co-authors
- Bruce Addis (1 shared paper)David Layfield (1 shared paper)Amit Agrawal (1 shared paper)William R. Roche (1 shared paper)Laurence Moore (1 shared paper)Mario Campone (1 shared paper)Sun‐Young Kong (1 shared paper)Simona D’Amore (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Research (4 papers)Annals of Oncology (3 papers)Histopathology (2 papers)Endoscopy (1 paper)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
H. Roché
23 papers receiving 534 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 161
- Oncology 245
- Pulmonary and Respiratory Medicine 167
- Pathology and Forensic Medicine 57
- Genetics 26
Countries citing papers authored by H. Roché
This map shows the geographic impact of H. Roché's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Roché with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Roché more than expected).
Fields of papers citing papers by H. Roché
This network shows the impact of papers produced by H. Roché. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Roché. The network helps show where H. Roché may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Roché, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 84 | |
| 2 | 2005 | 81 | |
| 3 | 2009 | 59 | |
| 4 | 2008 | 50 | |
| 5 | 1988 | 44 | |
| 6 | 2009 | 43 | |
| 7 | 2007 | 30 | |
| 8 | 2012 | 26 | |
| 9 | 2011 | 25 | |
| 10 | 2006 | 22 | |
| 11 | [Primary dural lymphoma: a report of two cases with review of the literature]. | 2003 | 22 |
| 12 | 1990 | 19 | |
| 13 | 2016 | 11 | |
| 14 | 2008 | 9 | |
| 15 | 2015 | 7 | |
| 16 | 2018 | 6 | |
| 17 | 2009 | 5 | |
| 18 | 2000 | 4 | |
| 19 | 2016 | 3 | |
| 20 | 2004 | 3 |
About H. Roché
H. Roché is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Molecular Biology, having authored 24 papers that have together received 557 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (3 papers), DNA Repair Mechanisms (2 papers), Occupational and environmental lung diseases (2 papers), PARP inhibition in cancer therapy (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Cancer Research (161 citations), Oncology (245 citations), Pulmonary and Respiratory Medicine (167 citations), Pathology and Forensic Medicine (57 citations) and Genetics (26 citations). H. Roché has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Bruce Addis, David Layfield, Amit Agrawal, William R. Roche, Laurence Moore, Mario Campone, Sun‐Young Kong, Simona D’Amore, J. Carpenter and Agnieszka Jagiełło-Gruszfeld. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Histopathology and Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.